Search Results
MK4 for MDS and AML: Molecular Mechanisms, Clinical Trials and Case Reports
Vitamin K2 MK-4 As Treatment for MDS and AML - A Discussion
2014 Annual Hematology Meeting: MDS, ALL, & AML
New Biomarkers and Prognostic Indicators in Leukemia and MDS
Dr. Wetzler on CDX-1401 in Combination with Decitabine in Patients with MDS
Non-Transplant Treatment for MDS
New drug breakthrough shows promise for AML patients
Weill Cornell Medical College Selected to Join New MDS Clinical Research Consortium
Dr. Shulman on the Complexities of Molecular Testing
Introduction: Treatment Landscape of MDS
Highlights from ASH 2015 by Alan Burnett, MD on acute myeloid leukemia (AML)
UQ research may lead to drug to fight leukaemia
